In order to investigate the relevance of experimental findings for corresponding human pathology, we analyzed the concentration of Gal-3 in serum samples of healthy controls and in patients with UC who were divided into three groups based on the disease severity (UC patients with mild, moderate and severe colitis) (Table 1). Here, LGALS3 is linked to colitis.